Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

Share Price is delayed by 15 minutes
Get Live Data
480.00    7.50 (1.59%)
Bid:
470.00
Ask:
490.00
Spread: 20.00 (4.255%)
Market Cap: £145.07m
EYE Live PriceLast checked at - London Stock Exchange

Intraday Eagle Eye Share Chart

Issue of Equity

18 Dec 2025 10:43

RNS Number : 1351M
Eagle Eye Solutions Group PLC
18 December 2025
 

18 December 2025

Eagle Eye Solutions Group PLC

("Eagle Eye" or the "Company")

 

Issue of equity

 

Eagle Eye, a leading SaaS and AI technology company that creates digital connections enabling personalised, real-time marketing at scale, announces that it has applied for the admission to trading on AIM of 10,000 new ordinary shares of 1p each in the Company ("Ordinary Shares") following the exercise of certain options over Ordinary Shares. Dealings are expected to commence on 24 December 2025.

Following the issue of the 10,000 new Ordinary Shares, the total number of Ordinary shares in issue as at the date of this notice is 30,166,520 with each share carrying the right to one vote. There are 193,000 shares held in Treasury. The total number of voting rights in the Company is, therefore, 29,973,520.

The above figure of 29,973,520 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Eagle Eye Solutions Group plc

Tel: 0844 824 3686

Tim Mason, Chief Executive Officer

 

Lucy Sharman-Munday, Chief Financial Officer

 

 

 

Investec Bank plc (Nominated Adviser and Joint Broker)

Tel: +44 20 7597 5970

David Anderson / Nick Prowting / James Smith

 

 

 

Shore Capital (Joint Broker)

Tel: +44 20 7408 4090

Corporate Advisory: Daniel Bush, David Coaten, Lucy Bowden

 

Corporate Broking: Henry Willcocks

 

 

 

Alma Strategic Communications

Tel: +44 20 3405 0205

Caroline Forde, Hannah Campbell, Kinvara Verdon

 

 

 

About Eagle Eye

 

Eagle Eye is a leading SaaS and AI company, enabling retail, travel and hospitality brands to earn lasting customer loyalty through harnessing the power of real-time, omnichannel and personalized marketing. Our powerful technology combines the world's most flexible and scalable loyalty and promotions capability with cutting edge, built-for-purpose AI to deliver 1:1 personalization at scale for enterprise businesses, globally.

 

Our growing customer base includes Loblaws, Southeastern Grocers, Giant Eagle, Asda, Tesco, Morrisons, JD Sports, E.Leclerc, Carrefour, the Woolworths Group and many more. Each week, more than 1 billion personalized offers are seamlessly executed via our platform, and over 700 million loyalty member wallets are managed worldwide. 

 

AI-powered, API-based and cloud-native, Eagle Eye's enterprise-grade technology is fully certified by the MACH Alliance and has received recognition from leading industry bodies, including Gartner, Forrester, IDC and QKS. 

 

Web - www.eagleeye.com  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFSIFLLTLIE
Date   Source Headline
28th May 20267:00 amRNSSale of shares from treasury
21st May 20262:47 pmRNSPDMR shareholding & issue of equity - replacement
21st May 20261:35 pmRNSPDMR shareholding and issue of equity
21st May 20267:00 amRNSCapital Markets Day
27th Apr 20267:00 amRNSNotice of Capital Markets Day
24th Apr 202612:30 pmRNSPDMR Shareholding
23rd Apr 20268:11 amRNSPDMR shareholding and issue of equity
31st Mar 20262:02 pmRNSPCA Shareholding
20th Mar 202610:36 amRNSDirector/PDMR Shareholding
17th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20267:00 amRNSHalf Year Results
17th Mar 20267:00 amRNSHalf Year Results
6th Mar 20267:00 amRNSTransaction in Own Shares & Programme Completion
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20265:18 pmRNSNotification of major holdings
2nd Mar 20262:43 pmRNSHolding(s) in Company
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20263:32 pmRNSDirector/PDMR Shareholding
12th Feb 202610:59 amRNSDirector/PDMR Shareholding
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSExtension of Share Buyback Long Stop Expiry Date
29th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSAppointment of Nominated Adviser and Joint Broker
23rd Jan 20263:48 pmRNSDirector Declaration Update
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSMajor US multi-year contract win
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.